Skip to main content
logo
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
9.07
-0.19 (-2.05%)
Sep 3, 2026, 12:00 PM EDT - Market open

Phathom Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
7201,180555523462596
Market Cap Growth
-16.63%112.56%6.22%13.23%-22.48%-36.35%
Enterprise Value
1,0901,628740535464461
Last Close Price
9.2616.598.129.1311.2219.67

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
3.056.7410.05766.45--
PB Ratio
--2.69-2.19-7.18-6.178.25
P/TBV Ratio
-----8.25

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.599.3013.39785.10--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.60-1.34-2.19-6.13-2.761.27
Net Debt / Equity Ratio
-1.07-1.05-1.02-0.89-0.68-1.27
Net Debt / EBITDA Ratio
-9.21-2.88-0.93-0.39-0.300.68
Net Debt / FCF Ratio
-10.01-2.75-0.96-0.46-0.350.62
Asset Turnover
0.830.550.140.00--
Inventory Turnover
7.355.183.61---
Quick Ratio
1.821.583.929.885.929.69
Current Ratio
1.921.734.2010.256.129.86
Return on Equity (ROE)
------108.01%
Return on Assets (ROA)
-8.80%-31.37%-43.78%-36.14%-60.85%-34.85%
Return on Capital Employed (ROCE)
-23.50%-125.90%-94.80%-44.60%-124.40%-79.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-13.56%-18.75%-60.21%-38.57%-42.83%-24.16%
FCF Yield
-5.05%-14.15%-48.07%-26.63%-31.97%-24.98%
Buyback Yield / Dilution
-11.72%-15.42%-23.18%-31.11%-5.72%-11.36%
SEC Filings: 10-K · 10-Q